Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrew Mills

Orthopaedic Trauma Springfield, IL Medical Doctor

NPI 1497142194 CMS profile 4220576

800 N 1St St, Springfield, IL 62702

Open in the dashboard

General payments

$8,537

64 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Andrew Mills of Springfield, IL is reported in the CMS Open Payments database as having received $8,537 across 64 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 48th percentile of Orthopaedic Trauma profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,799 7
2024 General $413 7
2023 General $2,005 19
2022 General $468 11
2021 General $848 13
2020 General $245 3
2019 General $760 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Mills
  • Orthopaedic Trauma median
  • Middle half of Orthopaedic Trauma
  • National median

In program year 2025, general payments to Andrew Mills were reported at $3,799. Among 734 Orthopaedic Trauma profiles paid that year, the median was $1,227 and the middle half received between $259 and $7,433.

Show as a table
Year Andrew Mills Orthopaedic Trauma median Middle half National median
2019 $760 $1,475 $264–$6,401 $163
2020 $245 $596 $120–$4,020 $114
2021 $848 $919 $171–$4,697 $132
2022 $468 $1,547 $272–$7,240 $149
2023 $2,005 $1,330 $247–$5,875 $160
2024 $413 $1,288 $277–$6,797 $164
2025 $3,799 $1,227 $259–$7,433 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. CurvaFix, Inc. $3,549 4 payments
  2. DePuy Synthes Sales Inc. $1,520 27 payments
  3. Medical Device Business Services, Inc. $905 7 payments
  4. Stryker Corporation $818 10 payments
  5. Pinnacle, Inc $760 4 payments
  6. Zimmer Biomet Holdings, Inc. $608 6 payments
  7. KLS-Martin L.P. $187 2 payments
  8. Integra LifeSciences Corporation $83 1 payment
  9. Smith+Nephew, Inc. $52 1 payment
  10. Biocomposites Inc $30 1 payment
  11. Other $25 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,824 58 payments
  2. Honoraria $3,250 1 payment
  3. Travel and Lodging $793 3 payments
  4. Education $670 2 payments
Products named General payments · program years 2019–2025
  1. CurvaFix IM Implant $3,549 4 payments
  2. TFN-Advance $1,095 16 payments
  3. MAKO $245 3 payments
  4. NA $221 6 payments
  5. A.L.P.S. $183 1 payment
  6. MATTA Non-Locking Plate $171 2 payments
  7. Affixus $163 2 payments
  8. MATTA Non-Locking Plate $131 2 payments
  9. GMRS $106 1 payment
  10. NCB $101 1 payment
  11. Other $1,367 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

132

Median for Orthopedic Surgery: 203

Drug cost

$748

Median for Orthopedic Surgery: $1,433

Branded share of claims

73.5%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 97 $687
Tramadol Hcl Generic 35 $61

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 92 billing codes

Paid by Medicare

$150,899

Medicare's payments for the services billed

Medicare patients

235

Average age 75

Services billed

855

158 women, 77 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 63%
Ischemic heart disease 44%
Depression 41%
Diabetes 37%
Heart failure 33%
Chronic kidney disease 33%
COPD 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

64 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Trauma in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record